MetaCap

Who Owns Capricor Therapeutics Stock?

NASDAQ: CAPRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.59+0.06 (+0.80%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
68.34%
Institutional holders
223
  • Institutions 68.3%
  • Insiders 9.4%
  • Public and other 22.2%

Who owns Capricor Therapeutics stock?

Institutional investors own about 68.3% of Capricor Therapeutics's shares, spread across 223 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 9.44% of CAPR.

The largest institutional holders are Blackrock Inc. (7.19%), State Street Corporation (5.19%) and RA Capital Management, L.P. (5.18%). Together, the top 10 institutions control 36.9% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their CAPR positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of CAPR

Capricor Therapeutics top institutional holders
InstitutionShares% HeldChange
Blackrock Inc.4.18M7.19%+0.8%
State Street Corporation3.02M5.19%-11.1%
RA Capital Management, L.P.3.01M5.18%+99.9%
Vanguard Capital Management LLC2.30M3.96%+0.3%
Shaw D.E. & Co., Inc.2.14M3.68%+1630.7%
Millennium Management Llc1.67M2.87%+613.5%
UBS Group AG1.40M2.41%+126.5%
EcoR1 Capital, LLC1.38M2.37%+100.0%
Longaeva Partners L.P.1.23M2.12%+1563.6%
Geode Capital Management, LLC1.14M1.96%-17.1%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of CAPR

Capricor Therapeutics top fund holders
FundShares% Held
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF1.78M3.06%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.66M2.85%
iShares Trust-iShares Russell 2000 ETF1.41M2.42%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund597.34K1.03%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund591.51K1.02%
iShares Trust-iShares Russell 2000 Growth ETF500.25K0.86%
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund308.38K0.53%
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund248.91K0.43%
VANGUARD WORLD FUND-Vanguard Health Care Index Fund140.88K0.24%
SCHWAB CAPITAL TRUST-Schwab Small-Cap Index Fund130.63K0.22%

Frequently asked questions

Who is the largest shareholder of Capricor Therapeutics?

Blackrock Inc. is the largest institutional shareholder of CAPR, owning 7.19% of shares outstanding (4.18M shares) as of its latest 13F filing.

What percentage of Capricor Therapeutics is owned by institutions?

Institutions own about 68.3% of CAPR shares and 75.5% of the public float.

How much of Capricor Therapeutics do insiders own?

Insiders, such as officers and directors, own about 9.44% of CAPR shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related